- Balanced growth across all business segments amid persistent uncertainty in the operating environment
SK Chemicals continued its growth trajectory, supported by sustained momentum across its core businesses.
SK Chemicals (CEO Ahn Jae-hyun) announced in a regulatory filing on May 8 that, on a separate (parent-company) basis, it posted revenue of KRW 385.7 billion and operating profit of KRW 21.2 billion in the first quarter of 2026. Revenue rose 14.2%, and operating profit surged 464.3%, both on a quarter-on-quarter basis.
The company explained that, even amid persistent economic uncertainty, revenue growth continued to be led by its core businesses, including copolyester and pharmaceuticals, which sustained the company’s growth momentum. The performance reflects relatively stable demand across its key business areas.
A representative of SK Chemicals said, “Despite significant external volatility in the first quarter, our operations across raw material procurement, production, and sales remained relatively stable, allowing us to maintain our revenue growth trajectory. To prepare for uncertainties such as oil price volatility and supply chain instability, we will conduct a thorough review of our product portfolio, cost structure, and operational processes to strengthen our underlying competitiveness and build a structure that can respond more flexibly to market changes.”
Separately, on a consolidated basis including subsidiary SK Bioscience, the company posted revenue of KRW 655.9 billion and an operating loss of KRW 18.9 billion.
[Photo caption: SK Chemicals’ headquarters located in Pangyo, Seongnam, Gyeonggi Province, Korea]